AstraZeneca Pharma receives nod from DCGI for Osimertinib tablets Ruby Khatun Khatun2 Jun 2017 11:15 AM ISTIndia: AstraZeneca Pharma Limited announced that it has received import and market permission in Form 45 (Marketing Authorisation) from the Drug...
Aurobindo Pharma receives USFDA approval to manufacture ADHD drug Ruby Khatun Khatun2 Jun 2017 10:25 AM ISTNew Delhi: Aurobindo Pharma has received final approval from the US health regulator for generic version of Strattera capsules, used in treatment of...
Cadila Healthcare posts Q4 net profit at Rs 385.5 cr Ruby Khatun Khatun2 Jun 2017 9:50 AM ISTNew Delhi: Drug firm Cadila Healthcare reported consolidated net profit at Rs 385.5 crore for the quarter ended March 31.The company had posted a net...
Glenmark gets USFDA nod for ADHD drug Ruby Khatun Khatun2 Jun 2017 9:21 AM ISTNew Delhi: Glenmark Pharmaceuticals has received final approval from the US health regulator for generic version of Strattera capsules, used in the...
Teva Pharmaceutical migraine drug clears late-stage study Ruby Khatun Khatun2 Jun 2017 9:21 AM ISTTeva Pharmaceutical Industries Ltd said on Wednesday its experimental drug to prevent migraine cleared a late-stage study, paving the way for a U.S....
EC Approves TRUMENBA-Pfizer’s Meningococcal Vaccine Ruby Khatun Khatun1 Jun 2017 12:27 PM ISTNEW YORK: Pfizer Inc. announced that the European Commission (EC) has approved TRUMENBA® (Meningococcal Group B Vaccine) for the prevention of...
Swiss biotech NLS Pharmas ADHD drug succeeds in mid-stage study Ruby Khatun Khatun1 Jun 2017 12:23 PM ISTSwiss biotech NLS Pharma AG said on Wednesday mid-stage trial data showed that its drug to treat attention deficit hyperactivity disorder (ADHD)...
Zydus Cadila gets USFDA nod for generic epilepsy drug Ruby Khatun Khatun1 Jun 2017 12:00 PM ISTNew Delhi: Drug firm Zydus Cadila has received the US health regulators nod to market Felbamate tablets, used to treat seizures in people with...
Gilead and GSK go head to head with similar HIV drug data Ruby Khatun Khatun1 Jun 2017 9:42 AM ISTGilead Sciences Inc and GlaxoSmithKline Plc (GSK) will go head-to-head with rival versions of an improved class of HIV medicines, after clinical...
Unichem Laboratories Q4 net profit up 13% at Rs 31.46 cr Ruby Khatun Khatun1 Jun 2017 9:10 AM ISTNew Delhi: Drug firm Unichem Laboratories reported a 13.61 per cent increase in standalone net profit at Rs 31.46 crore for the fourth quarter ended...
Natco Pharma Q4 surges nearly 3-fold at Rs 176.7 cr Ruby Khatun Khatun1 Jun 2017 9:01 AM ISTHyderabad: NATCO Pharma Limited has recorded consolidated total revenue of INR 2078.9 Crore for the year ended on 31 st March, 2017, as against INR...
Mylan may have overcharged US for EpiPen by 1.27 billion dollar: HHS Ruby Khatun Khatun1 Jun 2017 9:00 AM ISTNEW YORK: The U.S. government may have overpaid drugmaker Mylan N.V. by as much as $1.27 billion between 2006 and 2016 for its EpiPen emergency...
